ECSP045029A - Composiciones de valdecoxib de disgregación intraoral - Google Patents

Composiciones de valdecoxib de disgregación intraoral

Info

Publication number
ECSP045029A
ECSP045029A EC2004005029A ECSP045029A ECSP045029A EC SP045029 A ECSP045029 A EC SP045029A EC 2004005029 A EC2004005029 A EC 2004005029A EC SP045029 A ECSP045029 A EC SP045029A EC SP045029 A ECSP045029 A EC SP045029A
Authority
EC
Ecuador
Prior art keywords
compositions
intraoral
disgregation
valdecoxib
valdecoxib compositions
Prior art date
Application number
EC2004005029A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ECSP045029A publication Critical patent/ECSP045029A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Abstract

La presente invención se refiere a composiciones farmacéuticas de disgregación intraoral que contienen valdecoxib como ingrediente activo, a procesos para preparar dichas composiciones, y a métodos de tratamiento de trastornos mediados por la ciclooxigenasa-2 que comprenden administrar por vía oral dichas composiciones a un sujeto.
EC2004005029A 2001-09-26 2004-03-23 Composiciones de valdecoxib de disgregación intraoral ECSP045029A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32535601P 2001-09-26 2001-09-26

Publications (1)

Publication Number Publication Date
ECSP045029A true ECSP045029A (es) 2004-04-28

Family

ID=23267542

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005029A ECSP045029A (es) 2001-09-26 2004-03-23 Composiciones de valdecoxib de disgregación intraoral

Country Status (25)

Country Link
US (1) US20030181501A1 (es)
EP (2) EP1490035A1 (es)
JP (2) JP2005506987A (es)
KR (2) KR20040058189A (es)
CN (2) CN1703203A (es)
AP (2) AP2004002998A0 (es)
AR (1) AR037239A1 (es)
BR (2) BR0212861A (es)
CA (2) CA2461630A1 (es)
CO (2) CO5570659A2 (es)
EA (2) EA200400352A1 (es)
EC (1) ECSP045029A (es)
GE (1) GEP20063856B (es)
HK (1) HK1079988A1 (es)
IL (2) IL160855A0 (es)
IS (2) IS7178A (es)
MA (2) MA27682A1 (es)
MX (2) MXPA04002798A (es)
NO (2) NO20041258L (es)
OA (2) OA13060A (es)
PL (2) PL369298A1 (es)
TN (2) TNSN04045A1 (es)
WO (2) WO2003026697A2 (es)
YU (1) YU34804A (es)
ZA (2) ZA200401953B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005002557A1 (en) * 2003-07-03 2005-01-13 Warner-Lambert Company Llc Pharmaceutical compositions including an ether and selective cox-2 inhibitor and uses thereof
US20050186271A1 (en) * 2004-02-24 2005-08-25 Sheskey Paul J. Process for dispersing a fluid in a mass of solid particles
WO2006016602A1 (ja) * 2004-08-10 2006-02-16 Ajinomoto Co., Inc. 苦味の低減したナテグリニド含有製剤
EP1839650A1 (en) * 2004-12-28 2007-10-03 Eisai R&D Management Co., Ltd. Quick disintegration tablet and method of producing the same
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
WO2007072840A1 (ja) * 2005-12-20 2007-06-28 Eisai R & D Management Co., Ltd. 脂溶性薬物を含有する口腔内速崩錠
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8202535B2 (en) * 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8865743B2 (en) * 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US20090136570A1 (en) * 2006-01-20 2009-05-28 Bhagwant Rege Taste-Masked Tablets and Granules
US20070196494A1 (en) * 2006-02-17 2007-08-23 Arnaud Grenier Low-friability, patient-friendly orally disintegrating formulations
JP2009537554A (ja) * 2006-05-19 2009-10-29 ソマクソン ファーマシューティカルズ インコーポレイテッド 不眠症を治療するための、口腔内、舌下および急速融解製剤を含む、低用量ドキセピン製剤、ならびにその使用
CA2686964A1 (en) * 2007-06-06 2008-12-11 Basf Se Pharmaceutical formulation for the production of rapidly disintegrating tablets
EP2170273B1 (de) * 2007-06-06 2014-11-26 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
WO2008148731A1 (de) * 2007-06-06 2008-12-11 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
CN101686931B (zh) * 2007-06-06 2013-06-19 巴斯夫欧洲公司 用于制备可咀嚼片剂和锭剂的药物配制剂
DK2604257T3 (en) * 2007-08-07 2017-08-28 Acelrx Pharmaceuticals Inc ORAL TRANSMUCOSAL DOSAGE FORMS INCLUDING SUFENTANIL AND TRIAZOLAM
US20110086070A1 (en) * 2008-03-24 2011-04-14 Munish Talwar Orally disintegrating compositions of rhein or diacerein
US8945592B2 (en) * 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
CN102988318A (zh) * 2008-11-25 2013-03-27 田边三菱制药株式会社 口腔速崩片及其制备方法
US20110097401A1 (en) 2009-06-12 2011-04-28 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
US20110091544A1 (en) * 2009-10-16 2011-04-21 Acelrx Pharmaceuticals, Inc. Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting
FR2968995B1 (fr) * 2010-12-16 2013-03-22 Sanofi Aventis Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage
CN106822007B (zh) 2015-09-11 2021-12-31 西姆莱斯股份公司 口服制剂

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5576014A (en) * 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
US5633272A (en) * 1995-02-13 1997-05-27 Talley; John J. Substituted isoxazoles for the treatment of inflammation
PE10898A1 (es) * 1995-06-13 1998-03-20 American Home Prod Formulaciones orales de etodolac s (+)-
DK0855988T3 (da) * 1995-10-20 2002-08-19 Upjohn Co Blisterpakning
NZ332670A (en) * 1996-05-17 2000-07-28 Merck & Co Inc Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases comprising 3-phenyl-4-(4-methylsulfonyl)phenyl)-2-(5H)-furanone
EP0863134A1 (en) * 1997-03-07 1998-09-09 Merck Frosst Canada Inc. 2-(3,5-difluorophenyl)-3-(4-(methyl-sulfonyl)phenyl)-2-cyclopenten-1-one useful as an inhibitor of cyclooxygenase-2
US6465009B1 (en) * 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof
IL144763A0 (en) * 1999-12-08 2002-06-30 Pharmacia Corp Valdecoxib compositions
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
US6800297B2 (en) * 2000-06-15 2004-10-05 Acusphere, Inc. Porous COX-2 inhibitor matrices and methods of manufacture thereof
ATE329583T1 (de) * 2000-08-18 2006-07-15 Pharmacia Corp Schnell zerfallende orale arzneizubereitung enthaltend valdecoxib
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物

Also Published As

Publication number Publication date
MXPA04002798A (es) 2004-07-05
AP2004002998A0 (en) 2004-03-31
BR0212861A (pt) 2004-10-05
CA2461630A1 (en) 2003-04-03
US20030181501A1 (en) 2003-09-25
YU34804A (sh) 2006-08-17
TNSN04045A1 (fr) 2006-06-01
KR20040058189A (ko) 2004-07-03
MA27542A1 (fr) 2005-10-03
OA12707A (en) 2006-06-26
IL160855A0 (en) 2004-08-31
MA27682A1 (fr) 2006-01-02
IS7178A (is) 2004-03-11
OA13060A (en) 2006-11-10
AP2004002999A0 (en) 2004-03-31
NO20041532L (no) 2004-04-15
EP1490035A1 (en) 2004-12-29
PL369297A1 (en) 2005-04-18
CA2461044A1 (en) 2003-04-03
EA200400357A1 (ru) 2004-08-26
CN1633281A (zh) 2005-06-29
AR037239A1 (es) 2004-11-03
PL369298A1 (en) 2005-04-18
WO2003026623A1 (en) 2003-04-03
KR20040044990A (ko) 2004-05-31
TNSN04047A1 (fr) 2006-06-01
EA200400352A1 (ru) 2004-12-30
CN1703203A (zh) 2005-11-30
MXPA04002652A (es) 2004-06-07
IL160848A0 (en) 2004-08-31
HK1079988A1 (zh) 2006-04-21
JP2005512964A (ja) 2005-05-12
NO20041258L (no) 2003-03-27
WO2003026697A3 (en) 2003-07-03
ZA200401953B (en) 2005-05-09
JP2005506987A (ja) 2005-03-10
CO5570659A2 (es) 2005-10-31
IS7177A (is) 2004-03-11
WO2003026697A2 (en) 2003-04-03
GEP20063856B (en) 2006-06-26
EP1429736A2 (en) 2004-06-23
WO2003026623A8 (en) 2004-09-30
BR0212778A (pt) 2004-12-07
CO5570684A2 (es) 2005-10-31
ZA200402364B (en) 2005-01-13

Similar Documents

Publication Publication Date Title
ECSP045029A (es) Composiciones de valdecoxib de disgregación intraoral
NO20076508L (no) Acyloksykarbamat prodroger av traneksaminsyre og fremgangsmater for fremstilling og anvendelse derav
EP1558220A4 (en) ORAL COMPOSITIONS FOR THE TREATMENT OF DISEASES
SG157406A1 (en) Oral medicament for the modified release of at least one active principle, in multi-microcapsule form
UY35624A (es) Uso de dosis elevadas de pridopidina para tratar la enfermedad de huntington
MX2009003372A (es) Formas de dosificacion de pelicula no mucoadhesiva.
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
MY161593A (en) Oral formulations of cytidine analogs and methods of use thereof
UA90893C2 (ru) Пероральная дозированная форма производных гемцитабина
EA200702522A1 (ru) Система доставки лекарств в полость рта и способы ее применения
TR200900878A2 (tr) Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar
SE0300831D0 (sv) New formulations and use therof
FR2878161B1 (fr) Forme medicamenteuse orale, solide et concue pour eviter le mesusage
CO6270217A2 (es) Formulaciones galenicas de alisquireno y valsartan
PT1383752E (pt) 3-piperidinopropiofenonas deuteradas assim como farmacos contendo estes compostos
TR200900879A2 (tr) Aktif maddelerin tek bir dozaj formunda kombine edildiği farmasötik bileşimler
EA201170108A1 (ru) Сосательная композиция для лечения воспалительных заболеваний полости рта и глотки
WO2007144080A3 (de) Antidepressiva-kombinations-wafer
BRPI0516545A (pt) uso de óleo de lavanda para a profilaxia e tratamento de neurastenia, distúrbios de somatização e outras doenças associadas ao estresse
BRPI0513186A (pt) composição medicinal para a administração oral
MXPA05008843A (es) Sistema terapeutico que comprende amoxicilina y acido clavulanico.
ECSP045056A (es) Composiciones de valdecoxib de disgregación intraoral preparadas mediante un procedimiento de desecación por pulverizacion
CR7289A (es) Composiciones de valdecoxib de disgregacion intraoral
TR200900880A2 (tr) Tek bir dozaj formunda kombine edilen farmasötik bileşimler.
ATE493976T1 (de) Bakuchiol enthaltende pharmazeutische zusammensetzung zur behandlung von weiblicher osteoporose